

The Math Doesn't Work
You're selecting sites based on what they say they have. Not what they actually have.

Protocol to site list in four steps.

Upload your protocol
AI extracts I/E criteria and maps to medical codes

Find your patients
See where eligible patients receive care - by geography, volume, and care setting

Prioritize sites
Ranked by patient access, investigator experience, trial history, and competitive activity

Activate
Generate feasibility questionnaires and move to activation with audit-ready rationale
One platform across the site lifecycle

Patient Identification & Site Strategy
Find patients. Identify and score sites. Analyze competitive landscape.

Site Feasibility & Activation
Generate questionnaires. Track responses. Monitor activation readiness.

Portfolio & Operational Insights
Track enrollment vs. projections. Flag underperformers early. Benchmark across studies.
Built on the most complete US patient dataset
Powering decisions with depth, accuracy, and continuous refresh.

300M+
Patient journeys tracked from diagnosis to outcomes.

1M+
Providers mapped across regions and specialties.

Refresh
Monthly

In partnership with Komodo Health - the leading real-world data provider.
What Changes

3-6 months faster enrollment

Days to a defensible site list

Fewer zero-enrolling sites

Audit-ready rationale for governance

"The ability to connect the dots - zoom in on a specific question, but see it in context of the broader landscape - supports our strategic thinking across the portfolio. It's streamlined our workflows and democratized intelligence across the organization."
.png)
Global Head, Competitive & Strategic Intelligence | Leading Global Biopharma
Why teams choose us
Step 1
Komodo Health partnership
330M+ patient journeys. The most complete US real world dataset.
Step 2
Enterprise-ready in 2-4 weeks
No six-month implementations.
Step 3
Deployed at global pharma
Anervea's AI is already in production at Ipsen, Menarini, and other leading biopharma companies.
Step 4
Built by practitioners
Our team has run trials from Phase 1 through Phase 3. We know your reality.


.png)

